Search PubMed⌕ Search

Biomedical subjects

L Ni

Publications and source records attributed to L Ni.

76 records · Page 5Linked to original sources

Development of serotonin, substance P and thyrotrophin-releasing hormone in mouse medullary raphe grown in organotypic tissue culture: developmental regulation by serotonin.

Substance P (SP) and thyrotrophin-releasing hormone (TRH) are co-localized with serotonin (5-HT) in cells of the medullary raphe nuclei. In order to examine the factors that control development of multiple neurotransmitters within individual brain nuclei, we have grown presumptive raphe nuclei in organotypic tissue culture, an environment in which mammalian embryonic brain is easily accessible and manipulable. Tissue was obtained from E13 mice. A discrete midline segment of the rhombencephalon was dissected intact or was separated into 'rostral' (RR) and 'medullary' (MR) fragments. Tissue was explanted onto collagen coverslips and grown for up to two weeks in Maximow depression chambers. Tryptophan hydroxylase (TPH), the rate-limiting enzyme in 5-HT biosynthesis, was barely detectable at explantation. During the first week in culture, however, TPH activity increased 7-fold. After two weeks, TPH activity increased almost 2.5-fold above the one-week level. Immunocytochemical analysis of the cultures confirmed a widespread distribution of 5-HT-positive cells and fibers throughout the explant. SP, monitored by radioimmunoassay, was detected after two days in culture, and attained a level of 111.7 +/- 9.8 pg/culture after two weeks. TRH activity was similarly elevated after two weeks in vitro. Therefore, developmental increases in TPH, SP, and TRH occurred in culture, mimicking the condition in vivo. RR and MR fragments, when grown apart on separate coverslips, developed 1.57-2.26 times the TPH activity that developed in the undivided piece. Inclusion of 1 microM pargyline in the fragments restored TPH to control levels. The effect of pargyline was blocked by methiothepin, suggesting autoreceptor-mediated regulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Development of substance P-containing neurons in the central nervous system in mice: an immunocytochemical study.

The embryonic development of substance P (SP) in the central nervous system (CNS) of mice has been studied with the use of peroxidase antiperoxidase (PAP) immunocytochemistry. Immature SP-positive cells initially appear at embryonic day 12 (E12) in the epithalamus and in a column of cells extending from the myelencephalon throughout the length of the neural tube. By E13, SP-positive cells appear in the amygdaloid nuclear complex, the bed nucleus of the stria terminalis, and in the caudal medulla. Fibers are first detected in the stria terminalis at this age. Over the next 48 hours, a plethora of SP-positive cells appears throughout the CNS, notably in the septal area, diagonal band nucleus, piriform cortex, accumbens nucleus, hypothalamus, rostral striatum, superior and inferior colliculi, intercollicular nucleus, substantia nigra, interpeduncular nucleus, vestibular nuclei, spinal nucleus of the trigeminal, and the nucleus of the tractus solitarii. Subsequently, SP-positive neurons and fibers increase in number and staining intensity except in the medullary raphe where the apparent number of SP-positive neurons decreases after E16. Whereas the pattern of SP staining is quite similar in mice and rats, the time of initial detection of SP-like immunoreactivity in specific nuclei is 1-4 days earlier in mice than that reported in rats with different antisera.

Aging↗

Non-linear renal and biliary clearances of antiviral polyoxometalates in rats.

The polyoxometalates, JM 1591 (K12H2[P2W12O48].24 H2O), JM 1596 (K10[P2W18Zn4(H2O)2O68].20 H2O), and JM 2820 ([Me3NH]8[Si2W18Nb6O77]) have been shown to have potent activity against HIV-1 and HIV-2. The pharmacokinetics of JM 1591, JM 1596 and JM 2820 after intravenous administration of 50 mg/kg were investigated in rats. Renal and biliary clearances of the three compounds were found to be dependent on unbound plasma polyoxometalate concentration. Computer modeling was performed by fitting nonlinear pharmacokinetic models simultaneously to unbound plasma concentration, urinary excretion rate and biliary excretion rate versus time data. The renal clearances of JM 1591 and JM 2820 were described by glomerular filtration, saturated active tubular secretion at all plasma concentrations observed and saturable active tubular reabsorption. The urinary excretion of JM 1596 was characterized by glomerular filtration, saturable active tubular secretion and apparent linear reabsorption. Biliary clearances of all three polyoxometalates were described by a Michaelis-Menten function.

Animals↗